The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184

Pharmacology Biochemistry and Behavior

Volumn 124, Issue , 2014, Pages 153-159

  Seillier, Alexandre ^a   Dominguez Aguilar, David ^a   Giuffrida, Andrea ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

2 Arachidonoyl glycerol; Anandamide; Cannabinoid; CB1; Gas chromatography mass spectrometry; Motor activity

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; ENZYME INHIBITOR; 1,3 BENZODIOXOLE DERIVATIVE; 4 [BIS(1,3 BENZODIOXOL 5 YL)HYDROXYMETHYL] 1 PIPERIDINECARBOXYLIC ACID 4 NITROPHENYL ESTER; ANXIOLYTIC AGENT; CARBAMIC ACID DERIVATIVE; JZL195; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG POTENCY; LIPID BRAIN LEVEL; LOCOMOTION; MALE; MASS FRAGMENTOGRAPHY; MOTOR ACTIVITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIOXOLES; CARBAMATES; ENDOCANNABINOIDS; MALE; MOTOR ACTIVITY; PIPERAZINES; PIPERIDINES; RATS; RATS, WISTAR;

EID: 84903121643     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.05.022     Document Type: Article

References (42)

1. J.L. Blankman, G.M. Simon, and B.F. Cravatt A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol Chem Biol 14 2007 1347 1356
2. J.J. Burston, L.J. Sim-Selley, J.P. Harloe, A. Mahadevan, R.K. Razdan, and D.E. Selley et al. N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase J Pharmacol Exp Ther 327 2008 546 553
3. J.W. Chang, M.J. Niphakis, K.M. Lum, A.B. Cognetta, C. Wang, and M.L. Matthews et al. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates Chem Biol 19 2012 579 588
4. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87
5. V. Di Marzo Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7 2008 438 455
6. V. Di Marzo, and L. De Petrocellis Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs Curr Med Chem 17 2010 1430 1449
7. V. Di Marzo, T. Bisogno, T. Sugiura, D. Melck, and L. De Petrocellis The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide Biochem J 331 Pt 1 1998 15 19
8. T.P. Dinh, D. Carpenter, F.M. Leslie, T.F. Freund, I. Katona, and S.L. Sensi et al. Brain monoglyceride lipase participating in endocannabinoid inactivation Proc Natl Acad Sci U S A 99 2002 10819 10824
9. T.P. Dinh, S. Kathuria, and D. Piomelli RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol Mol Pharmacol 66 2004 1260 1264
10. D. Fegley, S. Kathuria, R. Mercier, C. Li, A. Goutopoulos, and A. Makriyannis et al. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172 Proc Natl Acad Sci U S A 101 2004 8756 8761
11. J. Fu, G. Bottegoni, O. Sasso, R. Bertorelli, W. Rocchia, and M. Masetti et al. A catalytically silent FAAH-1 variant drives anandamide transport in neurons Nat Neurosci 15 2012 64 69
12. A. Giuffrida, L.H. Parsons, T.M. Kerr, F. Rodriguez de Fonseca, M. Navarro, and D. Piomelli Dopamine activation of endogenous cannabinoid signaling in dorsal striatum Nat Neurosci 2 1999 358 363
13. S.K. Goparaju, N. Ueda, H. Yamaguchi, and S. Yamamoto Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand FEBS Lett 422 1998 69 73
14. J. Haller, F. Matyas, K. Soproni, B. Varga, B. Barsy, and B. Nemeth et al. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission Eur J Neurosci 25 2007 2445 2456
15. S. Hardison, S.T. Weintraub, and A. Giuffrida Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations Prostaglandins Other Lipid Mediat 81 2006 106 112
16. A.G. Hohmann, R.L. Suplita, N.M. Bolton, M.H. Neely, D. Fegley, and R. Mangieri et al. An endocannabinoid mechanism for stress-induced analgesia Nature 435 2005 1108 1112
17. D.M. Kerr, B. Harhen, B.N. Okine, L.J. Egan, D.P. Finn, and M. Roche The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action Br J Pharmacol 169 2013 808 819
18. A.R. King, A. Duranti, A. Tontini, S. Rivara, A. Rosengarth, and J.R. Clapper et al. URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices Chem Biol 14 2007 1357 1365
19. S.G. Kinsey, J.Z. Long, S.T. O'Neal, R.A. Abdullah, J.L. Poklis, and D.L. Boger et al. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain J Pharmacol Exp Ther 330 2009 902 910
20. A.H. Lichtman, E.G. Hawkins, G. Griffin, and B.F. Cravatt Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo J Pharmacol Exp Ther 302 2002 73 79
21. A.H. Lichtman, D. Leung, C.C. Shelton, A. Saghatelian, C. Hardouin, and D.L. Boger et al. Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity J Pharmacol Exp Ther 311 2004 441 448
22. J.Z. Long, W. Li, L. Booker, J.J. Burston, S.G. Kinsey, and J.E. Schlosburg et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nat Chem Biol 5 2009 37 44
23. J.Z. Long, D.K. Nomura, and B.F. Cravatt Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism Chem Biol 16 2009 744 753
24. J.Z. Long, D.K. Nomura, R.E. Vann, D.M. Walentiny, L. Booker, and X. Jin et al. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo Proc Natl Acad Sci U S A 106 2009 20270 20275
25. W.R. Marrs, J.L. Blankman, E.A. Horne, A. Thomazeau, Y.H. Lin, and J. Coy et al. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors Nat Neurosci 13 2010 951 957
26. G. Marsicano, C.T. Wotjak, S.C. Azad, T. Bisogno, G. Rammes, and M.G. Cascio et al. The endogenous cannabinoid system controls extinction of aversive memories Nature 418 2002 530 534
27. M.J. McFarland, A.C. Porter, F.R. Rakhshan, D.S. Rawat, R.A. Gibbs, and E.L. Barker A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide J Biol Chem 279 2004 41991 41997
28. M.J. Niphakis, A.B. Cognetta, J.W. Chang, M.W. Buczynski, L.H. Parsons, and F. Byrne et al. Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors ACS Chem Neurosci 4 2013 1322 1332
29. E.B. Oleson, M.V. Beckert, J.T. Morra, C.S. Lansink, R. Cachope, and R.A. Abdullah et al. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum Neuron 73 2012 360 373
30. S.E. O'Sullivan Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br J Pharmacol 152 2007 576 582
31. D. Piomelli The endocannabinoid system: a drug discovery perspective Curr Opin Investig Drugs 6 2005 672 679
32. D. Piomelli The element of surprise Nat Med 14 2008 720 721
33. M. Pistis, S. Perra, G. Pillolla, M. Melis, G.L. Gessa, and A.L. Muntoni Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions Neuropharmacology 46 2004 115 125
34. R. Russo, J. Loverme, G. La Rana, T.R. Compton, J. Parrott, and A. Duranti et al. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice J Pharmacol Exp Ther 322 2007 236 242
35. S.M. Saario, O.M. Salo, T. Nevalainen, A. Poso, J.T. Laitinen, and T. Jarvinen et al. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes Chem Biol 12 2005 649 656
36. J.R. Savinainen, S.M. Saario, and J.T. Laitinen The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors Acta Physiol (Oxf) 204 2012 267 276
37. N.R. Sciolino, W. Zhou, and A.G. Hohmann Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats Pharmacol Res 64 2011 226 234
38. A. Seillier, A. Martinez, and A. Giuffrida Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors Neuropsychopharmacology 38 2013 1816 1824
39. J.L. Stewart, and L.R. McMahon The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys Br J Pharmacol 164 2011 655 666
40. J.L. Wiley, and B.R. Martin Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes Chem Phys Lipids 121 2002 57 63
41. J. Wiskerke, C. Irimia, B.F. Cravatt, T.J. De Vries, A.N. Schoffelmeer, and T. Pattij et al. Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study ACS Chem Neurosci 3 2012 407 417
42. S.G. Woodhams, A. Wong, D.A. Barrett, A.J. Bennett, V. Chapman, and S.P. Alexander Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat Br J Pharmacol 167 2012 1609 1619